Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Current Medical Research and Opinion
|
September 21, 2007
The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation
Thomas P Leist, Patrick Vermersch
Beitrage Zur Pathologie
|
December 1, 1977
The technique of death masks making
H H Jansen, P Leist
The Neurologist
|
July 13, 2004
Familial multiple sclerosis and other inherited disorders of the white matter
Bernadette Kalman, Thomas P Leist
Neuromolecular Medicine
|
July 2, 2003
A mitochondrial component of neurodegeneration in multiple sclerosis
Bernadette Kalman, Thomas P Leist
Clinical Neuropharmacology
|
January 19, 2011
Cladribine: mode of action and implications for treatment of multiple sclerosis
Thomas P Leist, Robert Weissert
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
December 31, 2005
Clinical-magnetic resonance imaging correlations in multiple sclerosis
Robert Zivadinov, Thomas P Leist
Neurology
|
December 30, 2009
Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics
Thomas P Leist, Steven Marks
Health Psychology and Behavioral Medicine
|
March 21, 2022
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability
Judith Bijoux Leist, Thomas P Leist
Cytokine
|
January 1, 1990
Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus
T P Leist, R M Zinkernagel
Infection and Immunity
|
October 1, 1979
Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli
P Leist-Welsh, A B Bjornson
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Current Medical Research and Opinion
|
September 21, 2007
The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation
Thomas P Leist, Patrick Vermersch
Beitrage Zur Pathologie
|
December 1, 1977
The technique of death masks making
H H Jansen, P Leist
The Neurologist
|
July 13, 2004
Familial multiple sclerosis and other inherited disorders of the white matter
Bernadette Kalman, Thomas P Leist
Neuromolecular Medicine
|
July 2, 2003
A mitochondrial component of neurodegeneration in multiple sclerosis
Bernadette Kalman, Thomas P Leist
Clinical Neuropharmacology
|
January 19, 2011
Cladribine: mode of action and implications for treatment of multiple sclerosis
Thomas P Leist, Robert Weissert
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
December 31, 2005
Clinical-magnetic resonance imaging correlations in multiple sclerosis
Robert Zivadinov, Thomas P Leist
Neurology
|
December 30, 2009
Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics
Thomas P Leist, Steven Marks
Health Psychology and Behavioral Medicine
|
March 21, 2022
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability
Judith Bijoux Leist, Thomas P Leist
Cytokine
|
January 1, 1990
Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus
T P Leist, R M Zinkernagel
Infection and Immunity
|
October 1, 1979
Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli
P Leist-Welsh, A B Bjornson
Page
of 8